Abstract

Abstract Diabetes, including all forms, remains a critical global health issue, affecting over 589 million adults and causing approximately 3.4 million deaths annually. Developing more relevant in vitro models for pancreatic islet functions is crucial for advancing diabetes research and therapy. Microfluidic platforms enable precise control over experimental conditions, notably the mechanical cues within the tissue microenvironment, thereby offering a powerful tool for studying cell behavior under physiologically relevant conditions. In this study, we introduce an automated stimulation platform for single-islet glucose-stimulated insulin secretion, while insulin quantification remains off-chip. This platform incorporates an integrated micro-pump and automated fluid handling, obviating the need for external injection devices. Using both EndoC-βH5® spheroids and human donor islets, we demonstrate that the platform ensures high islet viability and functionality. This scalable and reproducible system represents a significant advancement in-depth studies of islet function, with broad applications for diabetes research and personalized treatment strategies.

Affiliated Institutions

Related Publications

Molecular Defects in Diabetes Mellitus

The application of molecular biology to problems in diabetes mellitus has begun to reveal the underlying molecular defects contributing to the development of hyperglycemia. Isle...

1991 Diabetes 87 citations

Publication Info

Year
2025
Type
article
Citations
0
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

0
OpenAlex

Cite This

Vincent Agache, Marie Hut, Flora Clément et al. (2025). Integrated pneumatic micro-pump for automated glucose-stimulated insulin secretion in single-islet microfluidic platform. Biofabrication . https://doi.org/10.1088/1758-5090/ae2a72

Identifiers

DOI
10.1088/1758-5090/ae2a72